In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
Year: 2000
Type: article
Source: PubMed
Institutions: Henry Ford Health, Henry Ford Hospital
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W1808107661
